Related Experiment Video
Updated: Feb 28, 2026

09:30
Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
2.2K
A New Mixed All-Atom/Coarse-Grained Model: Application to Melittin Aggregation in Aqueous Solution.
Mee Y Shelley1, Myvizhi Esai Selvan2, Jun Zhao3
1Schrödinger, Inc. , 101 SW Main Street, Suite 1300, Portland, Oregon 97204, United States.
Journal of Chemical Theory and Computation
|June 22, 2017
Summary
We developed a new computational method, all-atom/coarse-grained (AACG), to efficiently model peptide aggregation. This approach accelerates simulations, revealing insights into melittin aggregate formation and influencing biologic design.
Area of Science:
- Computational chemistry
- Biophysics
- Molecular modeling
Background:
- All-atom models are computationally expensive for studying peptide aggregation.
- Peptide aggregation is crucial for understanding biologic formulation and function.
- Melittin is a model peptide known for its aggregation propensity.
Purpose of the Study:
- Introduce and validate a novel mixed-resolution simulation method (AACG) for peptide aggregation.
- Characterize the aggregation process of melittin using the AACG approach.
- Assess the impact of environmental factors on melittin aggregation.
Main Methods:
- Developed an all-atom/coarse-grained (AACG) simulation technique.
- Represented peptide atoms fully and water molecules as single sites.
- Incorporated long-range electrostatic interactions using Ewald summation.
Main Results:
- Achieved 3-4x speedup in CPU time and ~7x in diffusion compared to all-atom models.
- Observed melittin aggregate formation, characterizing size distribution and buried surface areas.
- Identified key interactions (e.g., π-cation, π-stacking) and demonstrated salt/temperature effects.
Conclusions:
- The AACG method is efficient for studying peptide aggregation and relevant for biologics.
- Simulations support the molten globule model for melittin aggregates.
- AACG can guide the formulation and design of therapeutic peptides.

